Valvular & structural heart disease

Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients

Circ Cardiovasc IntervPublished nonrandomized, prospective

Authors' conclusion

At 3 to 5 years, Harmony TPV replacement resulted in sustained valve competence, beneficial cardiac remodeling, and improved quality of life. Continued monitoring is needed to assess long-term outcomes and valve performance.

Study context

Population
Patients with severe pulmonary regurgitation in the native or surgically repaired right ventricular (RV) outflow tract who received a commercially available TPV22 or TPV25 Harmony devicecatheterized, 86 successfully implanted with a Harmony transcatheter pulmonary valve (TPV)
Participants
89 patients
Exposure
TPV22 vs TPV25
Outcome
≤mild pulmonary regurgitation
Follow-up
3 years
Methodological detailspooled cohort, Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study
  • Pooled cohort
  • Native Outflow Tract Early Feasibility Study, Harmony Pivotal Trial, and Continued Access Study

Main finding

As reported in the abstract

TPV22

all patients

TPV25

96%

Observational data: associations, not effects.

Further findings

Duration of follow-up

RV end-diastolic volume index, RV to left ventricular end-diastolic volume ratio, effective RV stroke volume (magnetic resonance imaging) · preimplant to 2 years

Significant improvements
all P <0.001

SF-36 quality-of-life scores · over 3 years

Improved after Harmony implantation and sustained

Arrhythmias

Early cases of ventricular tachycardia resolved; no new arrhythmias

Safety

Adverse events · up to 5 years

Deaths unrelated to the device or procedure
3
Endocarditis, treated (1 medically, 1 transcatheter debulking of a vegetation) and resolved
2
Patients with RV outflow tract obstruction or thrombosis resulting in valve-in valve procedures
6
Major stent fracture resulting in surgical explant
1

Original publication

Midterm Outcomes in a Pooled Cohort of Harmony Transcatheter Pulmonary Valve Recipients. Circ Cardiovasc Interv. Published 16 July 2025. doi:10.1161/circinterventions.125.015196

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.